-
EP1852433
European procedure
Extract from the Register of European Patents
EP About this file: EP1852433
| EP1852433 - CARBAZOLE DERIVATIVE, SOLVATE THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 28.09.2012 Database last updated on 31.08.2024 | Most recent event Tooltip | 28.09.2012 | No opposition filed within time limit | published on 31.10.2012 [2012/44] | Applicant(s) | For all designated states ZERIA PHARMACEUTICAL CO., LTD. 10-11, Nihonbashi Kobuna-cho, Chuo-ku Tokyo 103-8351 / JP | [2007/45] | Inventor(s) | 01 /
MURATA, Masakazu ZERIA PHARMACEUTICAL CO. LTD 10-11, Nihonbashi Kobuna-cho Chuo-ku Tokyo 1038351 / JP | 02 /
ITOKAZU, Yoshihiko ZERIA PHARMACEUTICAL CO. LTD 10-11, Nihonbashi Kobuna-cho Chuo-ku Tokyo 1038351 / JP | 03 /
NAKAO, Ryu ZERIA PHARMACEUTICAL CO. LTD. 10-11, Nihonbashi Kobuna-cho Chuo-ku Tokyo 1038351 / JP | [2011/47] |
| Former [2007/45] | 01 /
MURATA, Masakazu ZERIA PHARMACEUTICAL CO. LTD 10-11, Nihonbashi Kobuna-cho, Chuo-ku Tokyo 1038351 / JP | ||
| 02 /
ITOKAZU, Yoshihiko ZERIA PHARMACEUTICAL CO. LTD 10-11, Nihonbashi Kobuna-cho, Chuo-ku Tokyo 1038351 / JP | |||
| 03 /
NAKAO, Ryu ZERIA PHARMACEUTICAL CO. LTD. 10-11, Nihonbashi Kobuna-cho, Chuo-ku Tokyo 1038351 / JP | Representative(s) | Maughan, Sophie Louise, et al Scott & York Intellectual Property Ltd 45 Grosvenor Road St Albans, Hertfordshire AL1 3AW / GB | [N/P] |
| Former [2010/16] | Maughan, Sophie Louise, et al Scott & York Intellectual Property Ltd 45 Grosvenor Road St Albans, Hertfordshire AL1 3AW / GB | ||
| Former [2008/34] | Coates, Ian Harold, et al Scott & York Intellectual Property Limited 45 Grosvenor Road St. Albans Hertfordshire AL1 3AW / GB | ||
| Former [2007/45] | Coates, Ian Harold, et al Scott & York 45 Grosvenor Road St. Albans Hertfordshire AL1 3AW / GB | Application number, filing date | 05799893.2 | 28.10.2005 | [2007/45] | WO2005JP20250 | Priority number, date | JP20040316872 | 29.10.2004 Original published format: JP 2004316872 | [2007/45] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2006046779 | Date: | 04.05.2006 | Language: | EN | [2006/18] | Type: | A1 Application with search report | No.: | EP1852433 | Date: | 07.11.2007 | Language: | EN | The application published by WIPO in one of the EPO official languages on 04.05.2006 takes the place of the publication of the European patent application. | [2007/45] | Type: | B1 Patent specification | No.: | EP1852433 | Date: | 23.11.2011 | Language: | EN | [2011/47] | Search report(s) | International search report - published on: | JP | 04.05.2006 | (Supplementary) European search report - dispatched on: | EP | 21.06.2010 | Classification | IPC: | C07D413/12, C07D413/14, C07D417/12, A61K31/422, A61K31/427, A61K31/4439, A61P1/16, A61P3/04, A61P3/06, A61P3/10, A61P9/12 | [2011/47] | CPC: |
C07D413/12 (EP,KR,US);
A61K31/422 (KR);
A61K31/427 (KR);
A61P1/00 (EP);
A61P1/16 (EP);
A61P29/00 (EP);
A61P3/00 (EP);
A61P3/04 (EP);
A61P3/06 (EP);
A61P3/10 (EP);
A61P43/00 (EP);
A61P9/00 (EP);
|
| Former IPC [2007/45] | C07D413/12, C07D413/14, C07D417/12, A61K31/422, A61K31/427, A61K31/4439, A61P1/16, A61P3/04, A61P3/06, A61P3/10, A61P9/12, A61P43/00 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2007/45] | Extension states | AL | 16.05.2007 | BA | 16.05.2007 | HR | 16.05.2007 | MK | 16.05.2007 | YU | 16.05.2007 | Title | German: | CARBAZOLDERIVAT, SOLVAT DAVON UND PHARMAZEUTISCH UNBEDENKLICHES SALZ DAVON | [2007/45] | English: | CARBAZOLE DERIVATIVE, SOLVATE THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | [2007/45] | French: | DÉRIVÉ DE CARBAZOLE, SOLVATE DUDIT DÉRIVÉ, OU SEL DE QUALITÉ PHARMACEUTIQUE DUDIT DÉRIVÉ | [2007/45] | Entry into regional phase | 25.06.2007 | Translation filed | 16.05.2007 | National basic fee paid | 16.05.2007 | Search fee paid | 16.05.2007 | Designation fee(s) paid | 16.05.2007 | Examination fee paid | Examination procedure | 16.05.2007 | Examination requested [2007/45] | 09.08.2010 | Amendment by applicant (claims and/or description) | 30.05.2011 | Communication of intention to grant the patent | 22.09.2011 | Fee for grant paid | 22.09.2011 | Fee for publishing/printing paid | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 30.05.2011 | Opposition(s) | 24.08.2012 | No opposition filed within time limit [2012/44] | Fees paid | Renewal fee | 12.10.2007 | Renewal fee patent year 03 | 31.03.2008 | Renewal fee patent year 04 | 13.10.2009 | Renewal fee patent year 05 | 12.10.2010 | Renewal fee patent year 06 | 11.10.2011 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [ ] - No further relevant documents disclosed | International search | [A]WO2004024939 (UNIV GEORGETOWN [US], et al); | [A]WO2004048333 (SHENZHEN CHIPSCREEN BIOSCIENCE [CN]); | [A] - HENKE B R., "Peroxisome proliferator-activated receptor alpha/gamma dual agonists for the treatment of type 2 diabetes.", J MED CHEM., (2004), vol. 47, no. 17, pages 4118 - 4127, XP002995070 DOI: http://dx.doi.org/10.1021/jm030631e |